|
" New Drugs in Cancer Chemotherapy "
edited by Stephen K. Carter, Yoshi Sakurai, Hamoa Umezawa.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
731340
|
| Doc. No
|
:
|
b551126
|
| Main Entry
|
:
|
edited by Stephen K. Carter, Yoshi Sakurai, Hamoa Umezawa.
|
| Title & Author
|
:
|
New Drugs in Cancer Chemotherapy\ edited by Stephen K. Carter, Yoshi Sakurai, Hamoa Umezawa.
|
| Publication Statement
|
:
|
Berlin, Heidelberg: Springer Berlin Heidelberg, 1981
|
| Series Statement
|
:
|
Recent Results in Cancer Research, Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 76.
|
| Page. NO
|
:
|
(xiv, 338 pages)
|
| ISBN
|
:
|
3642815650
|
|
|
:
|
: 9783642815652
|
| Contents
|
:
|
The Analog Potential in Cancer Chemotherapy in the United States and Japan --;Anthracyclines --;Preclinical Rationale and Phase I Clinical Trial of the Adriamycin Analog, AD 32 --;Available Data from Carminomycin Studies in the United States: The Acute Intermittent Intravenous Schedule --;New Anthracycline Antibiotic Aclacinomycin A: Experimental Studies and Correlations with Clinical Trials --;Bleomycins --;Current Status of PEP Bleomycin Studies in Japan --;Phase I and II Study of a New Bleomycin Analog (Pepleomycin) --;Tallysomycin, A Third Generation Bleomycin Analog --;Fluorinated Pyrimidines --;Studies of Analogs of Fluorinated Pyrimidine in Japan --;The Pharmacology of Ftorafur (R, S-l-(Tetrahydro-2- Furanyl)-5-Fluorouracil) --;Nitrosoureas --;Current Status of Nitrosoureas Under Development in Japan --;PCNU Phase I Study in the Northern California Oncology Group --;Molecular Pharmacology of Nitrosoureas --;Mechanistic Approaches to New Nitrosourea Development --;Other New Drugs --;New Natural Products Under Development at the National Cancer Institute --;A Prospective Screening Program: Current Screening and its Status --;Selected Anticancer Drugs in Phase I Trials in the United States (1979-1980) --;Fundamental Studies on Bestatin: A Small Molecular Microbial Product Enhancing Immune Responses --;A Review of Clinical Studies on Bestatin, 1976-1978 --;Phase I-II Study of N4-Behenoyl-1-?-D-Arabino-furanosylcytosine --;Gastric Cancer --;The FAM Regimen for Gastric Cancer: A Progress Report --;Adjuvant Studies in Gastric Cancer in the United States --;Preliminary Results of a United States-Japan Cooperative Trial in Patients with Disseminated Gastric Cancer --;Oat Cell Lung Cancer --;Combined Modality Studies on Small Cell Carcinoma of the Lung- Current Status in Japan --;Small Cell Lung Carcinoma --;Recent Advances and Current Challenges --;Head and Neck Cancer --;Combination Chemotherapy of Head and Neck Cancer in the United States --;High-Dose Methotrexate and Cis-Platinum in the Treatment of Recurrent Head and Neck Cancer --;Breast Cancer --;Current Strategy in the Chemotherapy of Advanced Breast Cancer --;Recent Advances in Chemotherapy for Advanced Breast Cancer --;The Current Status of Adjuvant Chemotherapy in Breast Cancer.
|
| Abstract
|
:
|
San Francisco (USA), May 21-22, 1979. Annual Program Review Symposium / US Japan Joint Agreement on Cancer Research
|
| Subject
|
:
|
Medicine.
|
| Subject
|
:
|
Oncology.
|
| Subject
|
:
|
Toxicology.
|
| Added Entry
|
:
|
Hamoa Umezawa
|
|
|
:
|
Stephen K Carter
|
|
|
:
|
Yoshi Sakurai
|
| Parallel Title
|
:
|
San Francisco (USA), May 21-22, 1979. Annual Program Review Symposium / US Japan Joint Agreement on Cancer Research
|
| |